Compass Diversified Earnings Call Transcripts
Fiscal Year 2026
-
A $380 million cash acquisition of The Honey Pot Company brings a fast-growing, innovative feminine care brand with strong retail presence and significant growth potential. The deal leverages a low cost of capital, focuses on expanding brand awareness, and aligns with a long-term, partnership-driven strategy.
Fiscal Year 2025
-
2025 was marked by operational challenges and a major subsidiary bankruptcy, but core businesses delivered growth and resilience. 2026 guidance reflects cautious optimism, with a focus on deleveraging through asset sales and disciplined execution amid ongoing tariff and macroeconomic uncertainty.
-
Returned to normal operations after a challenging year, with Q3 sales up 3.5% and year-to-date net sales up 8.6%. Focus remains on deleveraging, disciplined asset sales, and generating $50–$100 million in free cash flow in 2026, while navigating macro and supply chain headwinds.
-
A major fraud at Lugano led to a restatement of financials, significant losses, and a Chapter 11 filing. Enhanced governance, risk management, and divestitures are underway to reduce leverage and restore confidence. The remaining subsidiaries are performing well, with growth in sales and EBITDA.
-
The organization has completed a strategic pivot to a high-growth, innovative portfolio, delivering mid-teens EBITDA growth in 2024 and targeting double-digit growth ahead. Capital structure improvements, disciplined M&A, and a values-driven culture support long-term value creation, with optimism for 2025 and a clear path to $1 billion subsidiary EBITDA by 2028.
Fiscal Year 2024
-
Double-digit sales growth and over 30% adjusted EBITDA increase marked a strong 2024, driven by strategic acquisitions, portfolio optimization, and robust consumer segment performance. 2025 guidance projects continued growth, with a focus on innovation, capital discipline, and risk management.
-
Q3 2024 saw double-digit revenue and record adjusted EBITDA growth, driven by strong branded consumer performance and disciplined capital allocation. Full-year guidance was raised, liquidity remains robust, and optimism for M&A activity in 2025 is high.
-
Q2 2024 saw 11% revenue and 27% adjusted EBITDA growth, led by strong branded consumer businesses, while industrial segments lagged. Guidance remains unchanged, with a mix shift favoring consumer verticals and continued focus on high-return growth and prudent capital allocation.